Drug name - Actonel

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7192938 APIL Method of treatment using bisphosphonic acid May, 2023

(7 months from now)

US7718634 APIL Method of treatment using bisphosphonic acid May, 2023

(7 months from now)

US7192938

(Pediatric)

APIL Method of treatment using bisphosphonic acid Nov, 2023

(1 year, 1 month from now)

US7718634

(Pediatric)

APIL Method of treatment using bisphosphonic acid Nov, 2023

(1 year, 1 month from now)

Drugs and Companies using RISEDRONATE SODIUM ingredient

Treatment: Prevention and treatment of osteoporosis; Treatment of osteoporosis in postmenopausal women

Dosage: TABLET;ORAL

More Information on Dosage
Strength Dosage Availability
5MG TABLET;ORAL Prescription
30MG TABLET;ORAL Prescription
35MG TABLET;ORAL Prescription
75MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** TABLET;ORAL Discontinued
150MG TABLET;ORAL Prescription

availability in other generic markets.

Click on the highlighted region to filter.